RDHL insider transaction filings
RedHill Biopharma Ltd. — 2 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-13. Screen RDHL transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-13 | 4 | Raday Gilead — Chief Operating Officer | Sale (S): 14,130,000 @ $0.00 · Option exercise (M): 28,150,000 (derivative) @ $0 | EDGAR |
| 2026-04-22 | 4 | Raday Gilead — Chief Operating Officer | Sale (S): 15,740,000 @ $0.00 · Option exercise (M): 30,780,000 (derivative) @ $0 | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=RDHL returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →